[go: up one dir, main page]

PE20060014A1 - Taxanos con sustituyentes lactiloxilo en el c7 - Google Patents

Taxanos con sustituyentes lactiloxilo en el c7

Info

Publication number
PE20060014A1
PE20060014A1 PE2005000247A PE2005000247A PE20060014A1 PE 20060014 A1 PE20060014 A1 PE 20060014A1 PE 2005000247 A PE2005000247 A PE 2005000247A PE 2005000247 A PE2005000247 A PE 2005000247A PE 20060014 A1 PE20060014 A1 PE 20060014A1
Authority
PE
Peru
Prior art keywords
benzoxicarbonyl
taxane
lactyloxyl
furanil
diasteroisomers
Prior art date
Application number
PE2005000247A
Other languages
English (en)
Inventor
Robert A Holton
Hyeong Baik Kim
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Publication of PE20060014A1 publication Critical patent/PE20060014A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A UNA PREPARACION FARMACEUTICA QUE COMPRENDE UN TAXANO CARACTERIZADO POR TENER UN SUSTITUYENTE LACTILOXILO EN EL C(7), DE FORMULA (I), EN DONDE X3 ES FURANILO, X5 ES T-BUTOXICARBONILO, Bz ES BENZOILO Y Ac ES ACETILO. ESTE TAXANO COMPRENDE UN CARBONO QUIRAL POR LO QUE PUEDEN ESTAR PRESENTES COMO DIASTEROISOMERO R O S, O UNA MEZCLA DE AMBOS DIASTEROISOMEROS: 7-((S)-(-)-2-HIDROXILOXIPROPIONIL)-2-FURANIL-DOCETAXEL Y 7-((R)-(+)-2-HIDROXILOXIPROPIONIL)-2-FURANIL-DOCETAXEL Y PUEDEN ESTAR PRESENTES EN UNA MEZCLA RACEMICA U OPTICAMENTE ACTIVA, CON UNA RELACION MOLAR DE LOS DIASTEROISOMEROS DE AL MENOS 5:1, 10:1, 20:1 DE UNO CON RELACION AL OTRO. ESTOS COMPUESTOS SE ENCUENTRAN EN FORMA CRISTALINA Y ES OBTENIDO MEDIANTE UN METODO QUE COMPRENDE LA CRISTALIZACION DEL TAXANO A PARTIR DE UNA SOLUCION. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA DE FORMA LIQUIDA O SOLIDA QUE LOS COMPRENDE, DE ADMINISTRACION POR VIA ORAL O PARENTERAL Y SON UTILES COMO AGENTES ANTITUMORALES
PE2005000247A 2004-03-05 2005-03-04 Taxanos con sustituyentes lactiloxilo en el c7 PE20060014A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55071204P 2004-03-05 2004-03-05

Publications (1)

Publication Number Publication Date
PE20060014A1 true PE20060014A1 (es) 2006-02-18

Family

ID=34975310

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000247A PE20060014A1 (es) 2004-03-05 2005-03-04 Taxanos con sustituyentes lactiloxilo en el c7

Country Status (11)

Country Link
US (1) US7160919B2 (es)
EP (1) EP1737444A4 (es)
JP (1) JP2007527432A (es)
CN (1) CN1960721A (es)
AR (1) AR048078A1 (es)
GT (1) GT200500041A (es)
PA (1) PA8625301A1 (es)
PE (1) PE20060014A1 (es)
SV (1) SV2006002036A (es)
TW (1) TW200540164A (es)
WO (1) WO2005087222A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104650109B (zh) * 2013-11-22 2019-01-01 江苏天士力帝益药业有限公司 紫杉烷类化合物
KR102420468B1 (ko) 2016-03-14 2022-07-13 위스콘신 얼럼나이 리서어치 화운데이션 올리고락트산 컨쥬게이트 및 향상된 항암 효능을 갖는 마이셀

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960790A (en) 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
FR2679230B1 (fr) 1991-07-16 1993-11-19 Rhone Poulenc Rorer Sa Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent.
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5227400A (en) 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5489601A (en) 1991-09-23 1996-02-06 Florida State University Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
SG46582A1 (en) 1991-09-23 1998-02-20 Univ Florida State 10-Desacetoxytaxol derivatives
US5714513A (en) 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
DK0552041T3 (da) 1992-01-15 2000-10-09 Squibb & Sons Inc Enzymatiske fremgangsmåder til spaltning af enantiomerblandinger af forbindelser, der er nyttige som mellemprodukter ved fr
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5200534A (en) 1992-03-13 1993-04-06 University Of Florida Process for the preparation of taxol and 10-deacetyltaxol
CA2130578A1 (en) 1992-04-17 1993-10-28 Geewananda P. Gunawardana Taxol derivatives
US5248796A (en) 1992-06-18 1993-09-28 Bristol-Myers Squibb Company Taxol derivatives
US5319112A (en) 1992-08-18 1994-06-07 Virgnia Tech Intellectual Properties, Inc. Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol
WO1994005282A1 (en) 1992-09-04 1994-03-17 The Scripps Research Institute Water soluble taxol derivatives
CA2100808A1 (en) 1992-10-01 1994-04-02 Vittorio Farina Deoxy paclitaxels
WO1994014787A1 (en) 1992-12-23 1994-07-07 Bristol-Myers Squibb Company Novel sidechain-bearing taxanes and intermediates thereof
US5703247A (en) 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
ES2193155T3 (es) * 1993-03-22 2003-11-01 Univ Florida State Taxanos que tienen la cadena lateral sustituida por furilo o tienilo.
CA2161328A1 (en) 1993-06-11 1994-12-22 Robert C. Kelly Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them
IL109926A (en) 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
TW397866B (en) 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
FR2711369B1 (fr) 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
US5415869A (en) 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
TW354293B (en) 1995-06-06 1999-03-11 Bristol Myers Squibb Co Prodrugs of paclitaxel derivatives
US5780653A (en) 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
CA2231837A1 (en) 1995-09-13 1997-03-20 Florida State University Radiosensitizing taxanes and their pharmaceutical preparations
US5767297A (en) 1997-02-05 1998-06-16 Ensuiko Sugar Refining Co., Ltd. Taxoid derivative and method of producing thereof
FR2745814B1 (fr) 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1997042181A1 (en) 1996-05-06 1997-11-13 Florida State University 1-deoxy baccatin iii, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
WO1997044026A1 (en) 1996-05-22 1997-11-27 Neuromedica, Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
US6136988A (en) 1998-04-10 2000-10-24 Hauser, Inc. 7-hexanoyltaxol and methods for preparing the same
US6146659A (en) 1998-07-01 2000-11-14 Neopharm, Inc. Method of administering liposomal encapsulated taxane
JP2003502401A (ja) 1999-06-21 2003-01-21 ナプロ バイオセラピューティクス,インコーポレイテッド C−2ヒドロキシル保護−n−アシル(2r,3s)−3−フェニルイソセリン活性化エステルおよびそれらの製造方法
WO2001025223A1 (en) 1999-10-06 2001-04-12 The Research Foundation Of State University Of New York Stabilization of taxane-containing dispersed systems
WO2001057013A1 (en) 2000-02-02 2001-08-09 Florida State University Research Foundation, Inc. Taxane formulations having improved solubility
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
US6673833B2 (en) * 2000-02-02 2004-01-06 Fsu Research Foundation, Inc. C7 heterosubstituted acetate taxanes
IT1319168B1 (it) 2000-03-17 2003-09-26 Indena Spa Derivati di condensazione ad attivita' antitumorale, loro metodo dipreparazione e formulazioni che li contengono.
CA2354486A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C7 ester substituted taxanes

Also Published As

Publication number Publication date
EP1737444A4 (en) 2008-05-21
SV2006002036A (es) 2006-03-16
JP2007527432A (ja) 2007-09-27
US7160919B2 (en) 2007-01-09
PA8625301A1 (es) 2006-06-02
US20050209311A1 (en) 2005-09-22
AR048078A1 (es) 2006-03-29
GT200500041A (es) 2005-10-24
WO2005087222A1 (en) 2005-09-22
TW200540164A (en) 2005-12-16
CN1960721A (zh) 2007-05-09
EP1737444A1 (en) 2007-01-03

Similar Documents

Publication Publication Date Title
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
PE20100447A1 (es) Solucion acuosa inyectable que contiene 4-[[(7r)-8-isopropil-7-etil-5,6,7,8-tetrahidro-5-metil-6-oxo-tetrahidropteridin-2-il]amino]-3-metoxi-n-[(1-ciclopropil-4-piperazinil)fenil]benzamida
AR038000A1 (es) Compuesto derivado de tien[2,3-d]pirimidin-2,4(1h,3h)-diona, composicion farmaceutica, proceso para su preparacion y su uso en la fabricacion de un medicamento
NO20072382L (no) (S)-(-)-1-(4-Fluorisokinolin-5-yl)-sulfonyl-2-metyl-1,4-homopiperazinhydroklorid dihydrat
CY1118836T1 (el) Αντι-ιϊκα φωσφονικα αναλογα
EA200501061A1 (ru) N-(1-бензил-2-оксо-2-(1-пиперазинил)этил)-1-пиперидинкарбоксамидные производные и родственные соединения в качестве cgrp-антагонистов для лечения головных болей
PE20050480A1 (es) Acido [2-(8,9-dioxo-2,6-diazabiciclo [5.2.0] non-1(7)-en-2-il)alquil]fosfonico y derivados
PE20060186A1 (es) Antagonistas de cgrp seleccionados, procedimientos para su preparacion asi como su uso como medicamento
PE20090620A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
PE20110152A1 (es) Nuevos derivados de sulfamida sustituida
PE20060692A1 (es) Inhibidores bace
PE20051170A1 (es) DERIVADOS DE PIRROL COMO INHIBIDORES DEL FACTOR Xa
AR053092A1 (es) Compuestos derivados de acido fenoxiacetico y compuestos intermediarios de sintesis
PE20090548A1 (es) Compuestos aza-biciclohexano como inhibidores de trombina
PE20050293A1 (es) Derivados de aminoacidos sustituidos con cicloalquilo, procedimiento para su preparacion y su uso como medicamentos
PE20050336A1 (es) Compuestos triciclicos como inhibidores de la proteina farnesil transferasa
PE20060014A1 (es) Taxanos con sustituyentes lactiloxilo en el c7
PE20060630A1 (es) Amidas sustituidas de acido tienopirrolcarboxilico, amidas del acido pirrolotiazolcarboxilico y analogos relacionados como inhibidores de la caseina cinasa ie
AR052772A1 (es) Formas cristalinas y proceso para preparar compuestos de espiro-hidantoina
AR082731A1 (es) 2-oxo- y 2-tioxo-dihidroquinolin-3-carboxamidas sustituidas como moduladoras de kcnq2/3
AR037123A1 (es) Compuestos sustituidos de 1h-quinoxalin-2-ona; metodo de preparacion del compuesto y medicamento que lo contiene
EA200601845A1 (ru) НОВЫЕ β-АГОНИСТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ
PE20060103A1 (es) Nuevas 5-acilindolinonas con contenido en cicloalquilo y su preparacion como medicamento
PE20080654A1 (es) Amidas con dos sustituyentes aromaticos como inhibidores del glyt1
AR022130A1 (es) Nuevos derivados de arilalcanoilo, los procesos para su preparacion, uso y las composiciones farmaceuticas que los contienen

Legal Events

Date Code Title Description
FA Abandonment or withdrawal